February, 2024
February 2024
M T W T F S S
 1234
567891011
12131415161718
19202122232425
26272829  
Summary of 10 new indications/approvals in Heme Malignancies by FDA Oncology in 2023 – Oncology Brothers
Jan 5, 2024, 17:31

Summary of 10 new indications/approvals in Heme Malignancies by FDA Oncology in 2023 – Oncology Brothers

Quoting Oncology Brothers on X/Twitter:

Summary of 10 new indications/approvals in Heme Malignancies (excluding CART) by FDA Oncology in 2023:

1. Zanubrutinib

2. Pirtobrutinib

3. Polatuzumab

4. Epcortimab

5. Glofitamab

6. Quizartinib

7. Talquetamab

8. Elranatamab

9. Ivosidenib”

Source: Oncology Brothers/X